Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6603486rdf:typepubmed:Citationlld:pubmed
pubmed-article:6603486lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6603486lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:6603486lifeskim:mentionsumls-concept:C0041633lld:lifeskim
pubmed-article:6603486lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:6603486lifeskim:mentionsumls-concept:C0020204lld:lifeskim
pubmed-article:6603486lifeskim:mentionsumls-concept:C0184511lld:lifeskim
pubmed-article:6603486lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:6603486lifeskim:mentionsumls-concept:C0332466lld:lifeskim
pubmed-article:6603486lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:6603486lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:6603486lifeskim:mentionsumls-concept:C0449851lld:lifeskim
pubmed-article:6603486pubmed:issue1lld:pubmed
pubmed-article:6603486pubmed:dateCreated1983-9-23lld:pubmed
pubmed-article:6603486pubmed:abstractTextAccelerated proliferation of hybridoma cells was observed in the presence of human umbilical cord serum (HUCS). This had very strong growth-promoting activity, even at a concentration of 2%. A comparison was made between HUCS and other B cell growth promoters, such as lipopolysaccharide (LPS) and dextran sulfate (DxS), macrophage supernatant, and human endothelial culture supernatant (HECS). The growth-promoting effect of HUCS was superior. Using a microcytotoxicity assay, we found no significant differences in the number of antibody producing clones with the various culture media, except for fetal calf serum.lld:pubmed
pubmed-article:6603486pubmed:languageenglld:pubmed
pubmed-article:6603486pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6603486pubmed:citationSubsetIMlld:pubmed
pubmed-article:6603486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6603486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6603486pubmed:statusMEDLINElld:pubmed
pubmed-article:6603486pubmed:monthAuglld:pubmed
pubmed-article:6603486pubmed:issn0022-1759lld:pubmed
pubmed-article:6603486pubmed:authorpubmed-author:Van RoodJ JJJlld:pubmed
pubmed-article:6603486pubmed:authorpubmed-author:BlomJJlld:pubmed
pubmed-article:6603486pubmed:authorpubmed-author:NaipalA MAMlld:pubmed
pubmed-article:6603486pubmed:authorpubmed-author:WesterwoudtR...lld:pubmed
pubmed-article:6603486pubmed:issnTypePrintlld:pubmed
pubmed-article:6603486pubmed:day12lld:pubmed
pubmed-article:6603486pubmed:volume62lld:pubmed
pubmed-article:6603486pubmed:ownerNLMlld:pubmed
pubmed-article:6603486pubmed:authorsCompleteYlld:pubmed
pubmed-article:6603486pubmed:pagination59-67lld:pubmed
pubmed-article:6603486pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:meshHeadingpubmed-meshheading:6603486-...lld:pubmed
pubmed-article:6603486pubmed:year1983lld:pubmed
pubmed-article:6603486pubmed:articleTitleImproved fusion technique. I. Human umbilical cord serum, a new and potent growth promoter, compared with other B cell and hybridoma activators.lld:pubmed
pubmed-article:6603486pubmed:publicationTypeJournal Articlelld:pubmed